Muscle quality as a complementary prognostic tool in conjunction with sarcopenia assessment in younger and older individuals.

Low MQ despite low prevalence rates of sarcopenia in both groups suggests a need for age-specific MQ cut-points. Muscle quality assessments might be useful complementary prognostic tools alongside existing sarcopenia definitions.